54 results
6-K
EX-99.1
PRQR
ProQR Therapeutics N.V
5 Jan 24
Current report (foreign)
7:08am
to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndrome
Collaboration expands ProQR’s commitment
424B5
PRQR
ProQR Therapeutics N.V
24 Apr 23
Prospectus supplement for primary offering
4:30pm
to creditors and equity holders of the Selling Shareholders;
through one or more underwriters on a firm commitment or best efforts basis; and
any combination
F-3
PRQR
ProQR Therapeutics N.V
29 Mar 23
Shelf registration (foreign)
4:53pm
Shareholders;
through one or more underwriters on a firm commitment or best efforts basis; and
any combination of the foregoing, or any other available
6-K
EX-10.1
fj01p tfw
23 Dec 22
Current report (foreign)
7:10am
6-K
EX-10.2
symr5lk
23 Dec 22
Current report (foreign)
7:10am
6-K
EX-99.2
qdp29rn3uj
4 Aug 22
Current report (foreign)
7:18am
6-K
EX-99.1
5fpk4wramr13
1 Jun 22
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates
7:05am
6-K
EX-99.1
ilg4p5hhdzykl tfjm8
13 Apr 22
ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy
7:09am
424B5
92n5b7m8lcn0
10 Mar 22
Prospectus supplement for primary offering
8:55am
F-3
cmf7dke01 kc40g
1 Mar 22
Shelf registration (foreign)
5:08pm
6-K
EX-10.2
pmnqo 9z2f
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
6-K
EX-10.3
zlor9
30 Dec 21
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
7:19am
424B5
k6e t5aape2u1
17 Nov 21
Prospectus supplement for primary offering
4:47pm
F-3
xve ssg00ra
4 Nov 21
Shelf registration (foreign)
5:02pm
6-K
EX-99.2
nqls4fztwidtq
4 Nov 21
Current report (foreign)
7:30am
6-K
EX-99.1
mc3je
4 Oct 21
ProQR Appoints Theresa Heggie as Chief Commercial Officer
8:21am
6-K
EX-10.1
bx960 fpbcaztr3qy
8 Sep 21
ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly
4:10pm